ECHO- Mitral Stenosis Flashcards

1
Q

T/F: patient with MS often asymptomatic until they develop AFib

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

T/F: patient with MS symptoms exacerbated during pregnancy

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Natural progression of Mitral Stenosis

A

it will took 10-15 years from onset of RF to symptoms (Class I-II)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Physical examination for MS

A

notable is Mitral Facies-> Malar Flush

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cardiac PE for MS

A

Opening Snap better heard with diaphragm
Loud S1
holodiastolic rumble/murmur using the bell of steth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

in MS, what is the relationship between S2 and Opening snap?

A

the shorter S2 to OS, the more severe the MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Echo Criteria for severe MS

A

Valve hemodynamics:
MVA ≤1.5cm2
Diastolic PHT ≥150ms

Hemodynamic Consequences:
- severely Dilated LA ( >48ml/m2)
- PASP > 50mmHg

**C- asymptomatic
**
D - symptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

in MS, why gradient is not included in the echo criteria/qualifier of severity?

A

gradient is highly dependent on HR.

in the report, include HR in the report.

***severe MS mean G of >10mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ECHO findings in MS, PLAX view

A

Hockey-stick appearance
doming of the AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

considered as the reference in measuring MVA

A

MVA planimetry

**measure in mid-diastole
include open commissures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Formula for MVA via PHT

A

MVA= 220/PHT

***PHT= Deceleration time x 0.29

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T/F: Doppler angle on incidence does not influence MVA by PHT

A

TRUE

but mean gradient will be affected.

see pic for example

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

see pic for the Q

A

A is the correct slope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

PITFALLS in MVA by PHT method

A

due to possible errors with change in LV and LA compliance

Do not use PHT in calcific mitral stenosis (MAC), AR, marked tachycardia, very high LA pressure, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Mitral Annulus Calcification?

A
  • chronic, degenerative process in the fibrous BASE of the mitral valve
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

formula for MVA by Continuity equation

A

MVA = SV/mitral VTI

16
Q

in MAC, what is the prefered method to measure MVA?

A
  • 2D or 3D planimetry

***do not use PHT

17
Q

Echo view to assess MAC?

A

PSAX view

but for anterior and posterior Annulus, you have to change the angle.

17
Q

what is the recommendation for exercise testing in MS?

A

Class I indication. if there is discrepancy between resting echo and clinical symptoms, exercise testing with doppler is recommended.

18
Q

Indication for exercise testing for MS with >1.5cm2 MVA?

A

for progressive MS (MVA >1.5cm2) but with exertional symptoms. see pic

18
Q

Indication for exercise testing for MS with ≤1.5cm2 MVA?

A

for asymptomatic MS with PASP of <50mmHg.

to evaluate the PASP

19
Q

Acceptable Wilkins score for mitral valve balloon annuloplasty

19
Q

Components of Wilkins Score

A
  • Mobility
  • Subvalvular Thickening
  • Thickening
  • Calcification
20
Q

aside from Wilkins score, what else should you check for a favorable outcome with PTMC?

A

Commissural calcification

21
Q

Recommendation for Degenerative MS?

A

Class IIb only
- for symptomatic severe MS attributable to extensive mitral annular calcification, valve intervention may be considered only after discussion of the high procedural risk.

21
Q

What are the contraindications for PMC in Rheumatic MS?

A
  • MVA >1.5cm2
  • LA thrombus
  • more than mild MR
  • Severe or bi-commisural calcification
  • absence of commissural fusion
  • severe concomitant AV disease or severe combined tricuspid stenosis and regurgitation requiring surgery
  • Concomitant CAD requiring Surgery
21
Q

Percutaneous Mitral Commissurotomy vs Surgery in severe MS? (ESC)

A

aHigh thromboembolic risk: history of systemic embolism, dense spontaneous contrast in the LA, new-onset AF. High-risk of haemodynamic decompensation: systolic pulmonary pressure >50 mmHg at rest, need for major NCS, desire for pregnancy.

bSurgical commissurotomy may be considered by experienced surgical teams in patients with contraindications to PMC.

cSee recommendations on indications for PMC and mitral valve surgery in clinically significant mitral stenosis in section 7.2.

dSurgery if symptoms occur for a low level ofexercise and operative risk is low.

22
Q

Class IIa recommendations for PMC?

A
  • PMC should be considered as initial treatment in symptomatic patients with suboptimal anatomy but no unfavorable clinical characteristics
  • PMC should be considered in asymptomatic patients without unfavorable clinical characteristics and anatomical characteristics for PMC and
    1. high thromboembolic risk - Hx of systemic embolism, dense spontaneous echo contrast in the LA, new-onset or paroxysmal Afib), and/or
    2. High risk hemodynamic decompensation - PASP >50mmHg, need for major NCS, desire for pregnancy

**Unfavourable characteristics for PMC can be defined by the presence of several of the following characteristics.

Clinical characteristics:
- old age,
-history of commissurotomy,
-New York Heart Association class IV,
-permanent AF,
-severe pulmonary hypertension.

Anatomical characteristics:
- echocardiographic score >8,
- Cormier score 3 (calcification of mitral valve of any extent as assessed by fluoro- scopy),
- very small MVA,
- severe tricuspid regurgitation.

23
Q

rheumatic vs MAC-related MS.
difference in terms of Anatomy, Epidemiology, Assessment and Treatment.

24
Q

follow up echo for Severe asymptomatic MS and moderate MS

A

asymptomatic severe MS - yearly
moderate MS - every 2-3 years